Announcements Trials
Browse Landscape

Status

Completed 11Unknown 4Recruiting 4Withdrawn 3Active not recruiting 3Enrolling by invitation 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Dermatologic 1Breast 1

Conditions

Melanoma 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Specimen Handling 7Educational Status 7Cisplatin 7Standard of Care 6Interviews as Topic 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Carboplatin 5Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Fluorouracil 4Drug Therapy 4lenvatinib 3camrelizumab 3Surveys and Questionnaires 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Lenalidomide 3Gemcitabine 3Fluorodeoxyglucose F18 3Exercise 3Early Intervention, Educational 3Dexamethasone 3Cytarabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × OTHER × Echocardiography × Clear all
NCT01173341 2026-02-09

Cardiotoxicity of Cancer Therapy (CCT)

Abramson Cancer Center at Penn Medicine

Enrolling by invitation
700 enrolled
Breast

Breast Neoplasms

NCT06605833 2025-10-01

CARD-IO

Royal Marsden NHS Foundation Trust

Enrolling by invitation
60 enrolled
Dermatologic

Melanoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡